{
    "10.1001_jamacardio.2018.1579": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 71,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": true,\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": true,\n        \"Anticoagulant\": false,\n        \"Statins\": true,\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": 55\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 14,\n        \"Mean PG\": 29,\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": \"N/A\",\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": \"N/A\"\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1001_jamainternmed.2016.9356": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 80,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": true,\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": true,\n        \"Calcium ion blocker\": true,\n        \"Diuretic\": true,\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": true,\n        \"Statins\": true,\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 12.0,\n        \"Mean PG\": 5.0,\n        \"Effective orifice area (EOA)\": 1.4,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"N/A\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": \"N/A\"\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1001_jamaneurol.2018.1178": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 80,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": \"N/A\",\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"Bioprosthetic valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"True\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": \"N/A\"\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": \"False\",\n        \"Adverse cardiovascular events\": \"Stroke\",\n        \"Stroke\": \"True\",\n        \"Life_Threatening_Bleeding\": \"False\",\n        \"Acute_Kidney_Injury\": \"False\",\n        \"Major vascular complication\": \"False\",\n        \"New-onset permanent pacemaker implantation\": \"False\",\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": \"False\",\n        \"30day_Myocardial_Infarction\": \"False\",\n        \"30day_Stroke\": \"False\",\n        \"30day_Heart_Failure_Readmission\": \"False\",\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ajmg.a.40377": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 48,\n        \"Sex\": \"N/A\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 35,\n        \"Maximum pressure gradient (PG)\": 57,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": 32,\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": 75,\n        \"Immediate post-procedural PG\": 10,\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": false,\n        \"1year_Myocardial_Infarction\": false,\n        \"1year_Stroke\": false,\n        \"1year_Heart_Failure_Readmission\": false,\n        \"Left ventricular ejection fraction (LVEF)\": 75,\n        \"Maximum PG\": 17,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22168": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 86,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": 7.8,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 60,\n        \"Maximum pressure gradient (PG)\": 31,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.70,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": 20.5,\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": true,\n        \"THV size ≥ 26 mm\": false,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": false,\n        \"Post-dilation\": true,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"severe\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"trivial\",\n        \"Maximum PG before discharge\": 8,\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": 1.22\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"trivial\"\n    }\n}\n```"
    },
    "10.1002_ccd.22199": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 66,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 40.0,\n        \"Maximum pressure gradient (PG)\": 65.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": 216.0,\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": 45.0,\n        \"Minimum annular diameter\": 27.0,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": 46.0,\n        \"Ascending aorta diameter\": 31.0,\n        \"Supreannular calcification\": false,\n        \"Annular calcification\": false,\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": false,\n        \"Post-dilation\": true,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": true,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"moderate\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"trivial\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"mild\"\n    }\n}\n```"
    },
    "10.1002_ccd.22378": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 88,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": false,\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": true,\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": false,\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": false,\n        \"Society of Thoracic Surgeons (STS) Score\": 27,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 35,\n        \"Maximum pressure gradient (PG)\": 65,\n        \"Mean PG\": 35,\n        \"Effective orifice area (EOA)\": 0.6,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": false,\n        \"Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 26,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"Transaortic\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": true,\n        \"Total time\": 107,\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": true,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22423": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 80,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": true,\n        \"New York Heart Association (NYHA) Classification\": \"IIb\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": true,\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": 18.0,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 47.5,\n        \"Maximum pressure gradient (PG)\": 68.0,\n        \"Mean PG\": 45.0,\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": 37.0,\n        \"Minimum annular diameter\": 25.5,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": 27.0,\n        \"Ascending aorta diameter\": 30.0,\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"Left-transaxillary\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"Mild\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"Mild\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"Mild\"\n    }\n}\n```"
    },
    "10.1002_ccd.22532": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 93,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 86,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.5,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": false,\n        \"Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": true,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22609": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 82,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": false,\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": false,\n        \"Atrial fibrillation\": false,\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": false,\n        \"Percutaneous coronary intervention (PCI)\": false,\n        \"Coronary artery bypass grafting (CABG)\": false,\n        \"Society of Thoracic Surgeons (STS) Score\": 11.0,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 79.0,\n        \"Maximum pressure gradient (PG)\": 121.0,\n        \"Mean PG\": 83.0,\n        \"Effective orifice area (EOA)\": 0.35,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": false,\n        \"Moderate mitral regurgitation\": false,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": false,\n        \"Annular calcification\": false,\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": false,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"mild\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"mild\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"mild\"\n    }\n}\n```"
    },
    "10.1002_ccd.22684": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": \"N/A\",\n        \"Sex\": \"N/A\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"N/A\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": \"N/A\",\n        \"30day_Myocardial_Infarction\": \"N/A\",\n        \"30day_Stroke\": \"N/A\",\n        \"30day_Heart_Failure_Readmission\": \"N/A\",\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22808": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 58,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": false,\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 57,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22861": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 86,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": 12.9,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 80,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.5,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": true,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": true,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": true\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": true,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life_Threatening_Bleeding\": \"N/A\",\n        \"Acute_Kidney_Injury\": \"N/A\",\n        \"Major vascular complication\": \"N/A\",\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": true,\n        \"30day_Myocardial_Infarction\": \"N/A\",\n        \"30day_Stroke\": \"N/A\",\n        \"30day_Heart_Failure_Readmission\": \"N/A\",\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22900": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 90,\n        \"Sex\": \"N/A\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 31.0,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 50.0,\n        \"Maximum pressure gradient (PG)\": 71.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.47,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": 25.0,\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life_Threatening_Bleeding\": \"N/A\",\n        \"Acute_Kidney_Injury\": \"N/A\",\n        \"Major vascular complication\": \"N/A\",\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": \"N/A\",\n        \"30day_Stroke\": \"N/A\",\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22902": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 82,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": true,\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": 48.8,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 34,\n        \"Maximum pressure gradient (PG)\": 35,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.7,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 26.5,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": true,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": true,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": true,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": 2,\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.22960": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 89,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": false,\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": false,\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 31.0,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 35.0,\n        \"Maximum pressure gradient (PG)\": 55.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.4,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 21.0,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": true,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life_Threatening_Bleeding\": \"N/A\",\n        \"Acute_Kidney_Injury\": \"N/A\",\n        \"Major vascular complication\": \"N/A\",\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": true,\n        \"30day_Myocardial_Infarction\": \"N/A\",\n        \"30day_Stroke\": \"N/A\",\n        \"30day_Heart_Failure_Readmission\": \"N/A\",\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23012": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 79,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": false,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 62,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.7,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 24.5,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23026": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 87,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": true,\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": true,\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 35.0,\n        \"Maximum pressure gradient (PG)\": 128.0,\n        \"Mean PG\": 70.0,\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": true,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": true,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": 45.0,\n        \"Maximum PG\": 63.0,\n        \"Mean PG\": 43.0,\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23038": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 78,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 10.3,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 46,\n        \"Mean PG\": 27,\n        \"Effective orifice area (EOA)\": 1.0,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": \"N/A\",\n        \"THV size ≥ 26 mm\": \"N/A\",\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"N/A\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": true,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": \"N/A\",\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": false,\n        \"1year_Myocardial_Infarction\": false,\n        \"1year_Stroke\": false,\n        \"1year_Heart_Failure_Readmission\": false,\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23044": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 81,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 16.0,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 99.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.3,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 19.0,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"Transaortic\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": false,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": 30.0,\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": 30.0,\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": 1.5\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": 30.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 1.5,\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23115": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 67,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": false,\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": false,\n        \"Atrial fibrillation\": true,\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": true,\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": false,\n        \"Percutaneous coronary intervention (PCI)\": false,\n        \"Coronary artery bypass grafting (CABG)\": false,\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 108,\n        \"Mean PG\": 56,\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": false,\n        \"Moderate mitral regurgitation\": true,\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": 2.3,\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": true,\n        \"Annular calcification\": true,\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"Direct aortic access\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"mild\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"mild\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"mild\"\n    }\n}\n```"
    },
    "10.1002_ccd.23155": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 73,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"< 30\",\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": true,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": true,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"mild\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"mild\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": \"N/A\",\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"mild\"\n    }\n}\n```"
    },
    "10.1002_ccd.23198": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 85,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 75.0,\n        \"Maximum pressure gradient (PG)\": 77.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.22,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 17.3,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": true,\n        \"THV size ≥ 26 mm\": false,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": true,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"trivial\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"trivial\",\n        \"Maximum PG before discharge\": 15.0,\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": 75.0,\n        \"Maximum PG\": 15.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 1.15,\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"trivial\"\n    }\n}\n```"
    },
    "10.1002_ccd.23228": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 92,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"IV\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 27.0,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 35.0,\n        \"Maximum pressure gradient (PG)\": 54.0,\n        \"Mean PG\": 54.0,\n        \"Effective orifice area (EOA)\": 0.4,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": 45.0,\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"mild\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"mild\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": 45.0,\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"mild\"\n    }\n}\n```"
    },
    "10.1002_ccd.23236": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 85,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": false,\n        \"Atrial fibrillation\": false,\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": true,\n        \"Anticoagulant\": true,\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": false,\n        \"Percutaneous coronary intervention (PCI)\": false,\n        \"Coronary artery bypass grafting (CABG)\": false,\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 88,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.8,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": false,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"Left subclavian\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"Grade I\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"Grade I\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": 13,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 2.7,\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"Moderate\"\n    }\n}\n```"
    },
    "10.1002_ccd.23351": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 86,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 4.2,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.7,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": 27,\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": true,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23451": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 83,\n        \"Sex\": \"N/A\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": true,\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": 10,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": true,\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": \"N/A\",\n        \"Conversion to Cardiopulmonary bypass (CPB)\": true,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"Stroke\",\n        \"Stroke\": true,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": true,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": true,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23452": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 80,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": \"N/A\",\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 55,\n        \"Maximum pressure gradient (PG)\": 46,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.9,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.23454": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 89,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 9.4,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 78,\n        \"Maximum pressure gradient (PG)\": 65,\n        \"Mean PG\": 65,\n        \"Effective orifice area (EOA)\": 0.83,\n        \"EOA Index\": 0.42,\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": false,\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": 14,\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"mild\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": true,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"mild\",\n        \"Maximum PG before discharge\": 14,\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": 72,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.24363": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 85,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"II\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 18.5,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 65.0,\n        \"Maximum pressure gradient (PG)\": 55.0,\n        \"Mean PG\": 13.0,\n        \"Effective orifice area (EOA)\": 0.5,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": false,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": 18.0,\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": true,\n        \"THV size ≥ 26 mm\": false,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": false,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": true,\n        \"Excessive oversizing ≥ 15%\": true,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"trace\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"trace\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.24368": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 85,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": true,\n        \"Society of Thoracic Surgeons (STS) Score\": 6.4,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 45.0,\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": \"N/A\",\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandabke valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": \"N/A\",\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": true,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": 25.0,\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.24378": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 85,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": true,\n        \"Hypertension\": true,\n        \"Hyperlipidemia\": true,\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": false,\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": false,\n        \"Society of Thoracic Surgeons (STS) Score\": 12.0,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 27.0,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": 6.0,\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 21.0,\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": true,\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": false,\n        \"Post-dilation\": false,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": true,\n        \"Annular rupture\": false,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": false,\n        \"Immediate post-procedural paravalvular leakage (PVL)\": false,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": false,\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": false,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": false,\n        \"Acute_Kidney_Injury\": false,\n        \"Major vascular complication\": false,\n        \"New-onset permanent pacemaker implantation\": false,\n        \"PVL before discharge\": false,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": 4.0,\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": false,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.24381": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 72,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": \"N/A\",\n        \"Chronic obstructive pulmonary disease (COPD)\": true,\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": \"N/A\",\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": \"N/A\",\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 6.1,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 45.0,\n        \"Maximum pressure gradient (PG)\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.6,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": true,\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 21.0,\n        \"Maximum annular diameter\": 22.0,\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": false,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": false,\n        \"Post-dilation\": true,\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": \"N/A\",\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": true,\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": \"N/A\",\n        \"Life_Threatening_Bleeding\": \"N/A\",\n        \"Acute_Kidney_Injury\": \"N/A\",\n        \"Major vascular complication\": \"N/A\",\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": \"N/A\",\n        \"30day_Myocardial_Infarction\": \"N/A\",\n        \"30day_Stroke\": \"N/A\",\n        \"30day_Heart_Failure_Readmission\": \"N/A\",\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    },
    "10.1002_ccd.24412": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 75,\n        \"Sex\": \"Male\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": true,\n        \"New York Heart Association (NYHA) Classification\": \"III\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": true,\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 16.6,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": 61,\n        \"Maximum pressure gradient (PG)\": 36,\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": 0.8,\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": \"N/A\",\n        \"Maximum annular diameter\": \"N/A\",\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": \"N/A\",\n        \"Transapical approach\": true,\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Balloon-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": false,\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": \"N/A\",\n        \"Excessive oversizing\": \"N/A\",\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": true,\n        \"PVL severity\": \"trivial\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": true,\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"N/A\",\n        \"Stroke\": false,\n        \"Life_Threatening_Bleeding\": true,\n        \"Acute_Kidney_Injury\": true,\n        \"Major vascular complication\": \"N/A\",\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"PVL before discharge\": true,\n        \"PVL severity\": \"severe\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": true,\n        \"30day_Myocardial_Infarction\": \"N/A\",\n        \"30day_Stroke\": \"N/A\",\n        \"30day_Heart_Failure_Readmission\": \"N/A\",\n        \"1year_all_cause_mortality\": \"N/A\",\n        \"1year_Myocardial_Infarction\": \"N/A\",\n        \"1year_Stroke\": \"N/A\",\n        \"1year_Heart_Failure_Readmission\": \"N/A\",\n        \"Left ventricular ejection fraction (LVEF)\": 40,\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": true,\n        \"PVL severity\": \"severe\"\n    }\n}\n```"
    },
    "10.1002_ccd.24468": {
        "content": "```json\n{\n    \"Baseline_Characteristics\": {\n        \"Age\": 84,\n        \"Sex\": \"Female\",\n        \"BMI\": \"N/A\",\n        \"BSA\": \"N/A\",\n        \"Diabetes mellitus\": \"N/A\",\n        \"Hypertension\": \"N/A\",\n        \"Hyperlipidemia\": \"N/A\",\n        \"Coronary artery disease\": true,\n        \"Chronic obstructive pulmonary disease (COPD)\": \"N/A\",\n        \"Dialysis\": \"N/A\",\n        \"Atrial fibrillation\": \"N/A\",\n        \"New York Heart Association (NYHA) Classification\": \"N/A\",\n        \"Angiotensin-converting enzyme inhibitor (ACEI)/Angiotensin II receptor blocker (ARB)\": \"N/A\",\n        \"Beta receptor blocker\": \"N/A\",\n        \"Calcium ion blocker\": \"N/A\",\n        \"Diuretic\": \"N/A\",\n        \"Aspirin\": \"N/A\",\n        \"Anticoagulant\": true,\n        \"Statins\": \"N/A\",\n        \"Myocardial infarction\": \"N/A\",\n        \"Percutaneous coronary intervention (PCI)\": true,\n        \"Coronary artery bypass grafting (CABG)\": \"N/A\",\n        \"Society of Thoracic Surgeons (STS) Score\": 9.5,\n        \"N-terminal pro-B-type natriuretic peptide (NT-proBNP)\": \"N/A\"\n    },\n    \"Preprocedural_Imaging_Assessment\": {\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum pressure gradient (PG)\": 106,\n        \"Mean PG\": 61,\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA Index\": \"N/A\",\n        \"Moderate aortic regurgitation\": \"N/A\",\n        \"Moderate mitral regurgitation\": \"N/A\",\n        \"Left ventricular end-diastolic volume\": \"N/A\",\n        \"Left ventricular end-systolic volume\": \"N/A\",\n        \"Annular area\": \"N/A\",\n        \"Aortic root diameter\": \"N/A\",\n        \"Minimum annular diameter\": 20,\n        \"Maximum annular diameter\": 23,\n        \"Annular perimeter\": \"N/A\",\n        \"Annular eccentricity\": \"N/A\",\n        \"Area derived annular diameter\": \"N/A\",\n        \"Perimeter derived annular diameter\": \"N/A\",\n        \"Sinotubular juction (STJ) diameter\": \"N/A\",\n        \"Sinus diameter\": \"N/A\",\n        \"Ascending aorta diameter\": \"N/A\",\n        \"Supreannular calcification\": \"N/A\",\n        \"Annular calcification\": \"N/A\",\n        \"Left ventricular outflow tract calcification\": \"N/A\",\n        \"Left coronary artery height\": \"N/A\",\n        \"Right coronary artery height\": \"N/A\"\n    },\n    \"Procedural_Details\": {\n        \"Transfemoral artery approach\": true,\n        \"Transapical approach\": \"N/A\",\n        \"Other approaches\": \"N/A\",\n        \"Transcatheter heart valve (THV) size ≤ 25 mm\": false,\n        \"THV size ≥ 26 mm\": true,\n        \"THVtype (Self-expandable valve/Balloon-expandable valve)\": \"Self-expandable valve\",\n        \"Pre-dilation\": true,\n        \"Post-dilation\": \"N/A\",\n        \"Total time\": \"N/A\",\n        \"Digital subtracted angiography (DSA) time\": \"N/A\",\n        \"DSA amount\": \"N/A\",\n        \"Immediate post-procedural LVEF\": \"N/A\",\n        \"Immediate post-procedural PG\": \"N/A\",\n        \"Post-procedural PG ≥ 20 mmHg\": true,\n        \"Mal-positioning\": \"N/A\",\n        \"Annular rupture\": true,\n        \"Excessive oversizing\": false,\n        \"Excessive oversizing ≥ 15%\": \"N/A\",\n        \"Immediate post-procedural paravalvular leakage (PVL)\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"THV displacement\": \"N/A\",\n        \"Conversion to surgical aortic valve replacement\": false,\n        \"Conversion to Cardiopulmonary bypass (CPB)\": false,\n        \"Valve-in-valve\": \"N/A\",\n        \"Periprocedural death\": false\n    },\n    \"Evaluation_Before_Discharge\": {\n        \"Death_before_Discharge\": false,\n        \"Adverse cardiovascular events\": \"Stroke\",\n        \"Stroke\": true,\n        \"Life_Threatening_Bleeding\": true,\n        \"Acute_Kidney_Injury\": \"N/A\",\n        \"Major vascular complication\": \"N/A\",\n        \"New-onset permanent pacemaker implantation\": \"N/A\",\n        \"PVL before discharge\": \"N/A\",\n        \"PVL severity\": \"N/A\",\n        \"Maximum PG before discharge\": \"N/A\",\n        \"Mean PG before discharge\": \"N/A\",\n        \"EOA index before discharge\": \"N/A\"\n    },\n    \"Follow-up_Characteristics\": {\n        \"30day_all_cause_mortality\": false,\n        \"30day_Myocardial_Infarction\": false,\n        \"30day_Stroke\": false,\n        \"30day_Heart_Failure_Readmission\": false,\n        \"1year_all_cause_mortality\": false,\n        \"1year_Myocardial_Infarction\": false,\n        \"1year_Stroke\": false,\n        \"1year_Heart_Failure_Readmission\": false,\n        \"Left ventricular ejection fraction (LVEF)\": \"N/A\",\n        \"Maximum PG\": \"N/A\",\n        \"Mean PG\": \"N/A\",\n        \"Effective orifice area (EOA)\": \"N/A\",\n        \"EOA index\": \"N/A\",\n        \"if PVL\": \"N/A\",\n        \"PVL severity\": \"N/A\"\n    }\n}\n```"
    }
}